About Interface Pharmaceuticals
Interface Pharmaceuticals is a company based in Delhi (India) founded in 1999 by Promila Malhotra and Sudhir Kumar Malhotra. It operates as a B2B. Interface Pharmaceuticals operates in a competitive market with competitors including Merck Animal Health, TARGAN, Intervacc, VitamFero and Pacific GeneTech, among others.
- Headquarter Delhi, India
- Founders Promila Malhotra, Sudhir Kumar Malhotra
- SectorsAgriculture
- Website interfacepharma.com
- Legal Name Interface Pharmaceuticals Pvt Ltd
- Date of Incorporation 14 Jun, 1999
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹22.92 Cr
FY 2025 · +13% YoY
- Net Profit₹2.03 Cr
FY 2025 · 9% margin
- EBITDA₹3.43 Cr
FY 2025 · 15% margin
Associated legal entities of Interface Pharmaceuticals
Interface Pharmaceuticals operates through Interface Pharmaceuticals Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Interface Pharmaceuticals Pvt Ltd CIN U24232DL1999PTC100229 | Active | 14 Jun 1999 | New Delhi, Delhi | ₹22.9 Cr | – | 4 | View details |
Board of directors of Interface Pharmaceuticals Pvt Ltd (Interface Pharmaceuticals)
Interface Pharmaceuticals Pvt Ltd is the primary company behind Interface Pharmaceuticals. The board of Interface Pharmaceuticals Pvt Ltd currently have 4 directors; the longest-serving is Sudhir Kumar Malhotra, appointed in 1999. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sudhir Kumar Malhotra DIN 00790742 | Director | 14 Jun 1999 | 27 yrs 3 mo | Interface Pharmaceuticals Pvt Ltd |
| Promila Malhotra DIN 01199902 | Director | 14 Jun 1999 | 27 yrs 3 mo | Interface Pharmaceuticals Pvt Ltd |
| Shilpa Malhotra DIN 08502333 | Director | 20 Oct 2019 | 6 yrs 11 mo | Interface Pharmaceuticals Pvt Ltd |
| Manan Malhotra DIN 06839663 | Director | 25 Jul 2022 | 4 yrs 2 mo | Interface Pharmaceuticals Pvt Ltd |
People of Interface Pharmaceuticals
2 people are tracked at Interface Pharmaceuticals (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Director | Leadership | |
| Co-Founder, Director | Leadership |
Complete people profiles for Interface Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Interface Pharmaceuticals
Figures of Interface Pharmaceuticals Pvt Ltd, the primary company behind Interface Pharmaceuticals, for FY 2025. Revenue was ₹22.92 Cr (+13% year on year). Net profit was ₹2.03 Cr (9% margin). EBITDA was ₹3.43 Cr (15% margin). Revenue has grown at a compounded annual rate of +9% over three years and +16% over five years.
- ₹22.92 CrRevenue · FY 2025 · +13% YoY
- ₹2.03 CrNet profit · 9% margin
- ₹3.43 CrEBITDA · 15% margin
- ₹10 LakhPaid-up capital
- +9%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Interface Pharmaceuticals Pvt Ltd are on its company page.
Detailed financial statements for Interface Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Interface Pharmaceuticals
Interface Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, Intervacc, VitamFero and Pacific GeneTech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| merck-animal-health.com | 1921 | Madison, United States | – | 2,952 | Vaccine technology is developed and supplied for livestock animals. | |
| targan.com | 2015 | Morrisville, United States | – | 29 | Automated targeted vaccine systems for livestock and aquaculture are developed. | |
| intervacc.se | 2001 | Stockholm, Sweden | – | – | Recombinant vaccines for cattle, equine, and other livestock are developed. | |
| vitamfero.com | 2005 | Angers, France | $6.72M | – | Offers patented immunostimulating vaccines for livestock. | |
| pacificgenetech.com | 2009 | Hong Kong, China | $10M | – | Developer of vaccines and gene delivery platform | |
| harrisvaccines.com | 2005 | Ames, United States | $5M | – | Developer of vaccine technology for the treatment of infectious diseases | |
| virovet.com | 2015 | Leuven, Belgium | $13.63M | 14 | Manufacturer and supplier of antiviral drugs for livestock | |
| verovaccines.com | 2017 | Halle, Germany | – | – | Developer of animal vaccines to treat infectious diseases | |
| automed.io | 2006 | Belconnen, Australia | – | – | Integrated livestock medication delivery and trace-ability platform |
Detailed competitors of Interface Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Interface Pharmaceuticals
The website of Interface Pharmaceuticals (interfacepharma.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 26.6% vs previous month
Similar companies to Interface Pharmaceuticals
10 companies that operate in the same segment as Interface Pharmaceuticals (Livestock Operations), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of chicken farming services | 1961 | Riyadh, Saudi Arabia | – | – | – | |
Manufacturer of processed, nutritional & feed supplements, egg powder, frozen poultry products | 1971 | Pune, Maharashtra, India | USD 263.03 K | USD 397.23 M | 5,620 | |
Colostrum-derived and nisin-based treatments for cattle health are developed. | 1982 | Portland, Oregon, United States | – | USD 27.64 M | 75 | |
Meat products are supplied to global markets from Israel. | 2019 | Rehovot, Central District, Israel | USD 9 M | – | 24 | |
Rusagro is recognized as a leading producer of sugar and edible oils in Russia. | 2003 | Moscow, Russia | – | – | – | |
Livestock animals are farmed and processed in an integrated approach. | 1983 | Dandong, Liaoning, China | – | USD 14.83 B | 49,900 | |
Sustainable feed additives for livestock are provided by Agteria. | 2023 | Stockholm, Sweden | USD 7.71 M | – | – | |
Livestock identification tags and tissue sampling units are manufactured. | 1972 | Dallas, Texas, United States | USD 106.01 M | – | – | |
Financial solutions, health products, and bird's nest exports are provided. | 1998 | Shah Alam, Selangor, Malaysia | – | USD 22.89 M | – | |
Beef, meat, and pork products are supplied to customers. | 2021 | Chicago, Illinois, United States | USD 11.5 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Interface Pharmaceuticals
Interface Pharmaceuticals was founded in 1999.
Interface Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Interface Pharmaceuticals, Interface Pharmaceuticals Pvt Ltd, reported revenue of ₹22.92 Cr for FY 2025, up 13% year on year.
Interface Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, focusing on animal health, immune modulation products, and livestock solutions. Develops and markets immune modulation products for livestock animals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Interface Pharmaceuticals's top competitors include TARGAN, Merck Animal Health and Intervacc.
Interface Pharmaceuticals operates through Interface Pharmaceuticals Pvt Ltd.
The legal entities of Interface Pharmaceuticals currently have 4 directors, including Sudhir Kumar Malhotra, Shilpa Malhotra, Promila Malhotra and others.